AAPL338.30-6.34 (-1.84%) ▼|ABBV287.75-7.14 (-2.42%) ▼|ABT108.53+2.33 (+2.19%) ▲|ACN260.97+2.73 (+1.06%) ▲|ADBE252.72+2.49 (+0.99%) ▲|AMAT393.50+3.41 (+0.87%) ▲|AMD492.72-12.09 (-2.39%) ▼|AMGN461.53-4.48 (-0.96%) ▼|AMT187.25-0.53 (-0.28%) ▼|AMZN251.70+11.35 (+4.72%) ▲|AVGO332.70+6.62 (+2.03%) ▲|AXP327.48+8.37 (+2.62%) ▲|BA176.42+4.87 (+2.84%) ▲|BAC50.02+0.01 (+0.02%) ▲|BKNG155.00+6.87 (+4.64%) ▲|BLK1,174.36+26.82 (+2.34%) ▲|BMY62.54+0.06 (+0.09%) ▲|BNY148.04+0.93 (+0.63%) ▲|BRK-B550.78+8.29 (+1.53%) ▲|C123.59+1.62 (+1.33%) ▲|CAT619.65-3.10 (-0.50%) ▼|CL96.39+1.10 (+1.15%) ▲|CMCSA23.62+0.40 (+1.70%) ▲|COF210.48+5.63 (+2.75%) ▲|COP149.02-5.02 (-3.26%) ▼|COST1,027.81+15.53 (+1.53%) ▲|CRM231.15+1.98 (+0.86%) ▲|CSCO103.54-0.97 (-0.93%) ▼|CVS88.29-1.96 (-2.17%) ▼|CVX231.07-4.46 (-1.89%) ▼|DE674.37-1.11 (-0.16%) ▼|DHR228.23-4.00 (-1.72%) ▼|DIS112.91+1.97 (+1.78%) ▲|DUK127.09-0.30 (-0.24%) ▼|EMR168.84+3.90 (+2.36%) ▲|FDX320.10+6.82 (+2.18%) ▲|GD369.87-2.72 (-0.73%) ▼|GE313.61+11.81 (+3.91%) ▲|GEV889.40+31.53 (+3.68%) ▲|GILD167.87-2.81 (-1.65%) ▼|GM89.32+1.92 (+2.20%) ▲|GOOG281.51+3.29 (+1.18%) ▲|GOOGL283.11+3.27 (+1.17%) ▲|GS911.73+17.18 (+1.92%) ▲|HD338.79+9.59 (+2.91%) ▲|HON224.57+6.24 (+2.86%) ▲|IBM259.55+1.74 (+0.67%) ▲|INTC63.06-2.71 (-4.11%) ▼|INTU351.96+10.87 (+3.19%) ▲|ISRG440.39+8.38 (+1.94%) ▲|JNJ268.46-4.74 (-1.74%) ▼|JPM340.52+3.48 (+1.03%) ▲|KO95.08+1.00 (+1.06%) ▲|LIN520.56+6.32 (+1.23%) ▲|LLY1,409.41-8.14 (-0.57%) ▼|LMT637.85+0.90 (+0.14%) ▲|LOW216.09+7.02 (+3.36%) ▲|LRCX236.32-2.80 (-1.17%) ▼|MA657.31+19.30 (+3.02%) ▲|MCD263.20+5.08 (+1.97%) ▲|MDLZ65.78+0.84 (+1.29%) ▲|MDT97.69+1.15 (+1.19%) ▲|META610.35-4.64 (-0.75%) ▼|MMM179.02+4.68 (+2.68%) ▲|MO77.53-0.51 (-0.65%) ▼|MRK148.15-1.37 (-0.92%) ▼|MS186.83+2.53 (+1.37%) ▲|MSFT524.18+2.27 (+0.43%) ▲|MU868.15-16.59 (-1.88%) ▼|NEE84.44+0.73 (+0.87%) ▲|NFLX62.01-0.07 (-0.11%) ▼|NKE39.35+0.68 (+1.76%) ▲|NOW107.66+2.54 (+2.42%) ▲|NVDA207.32+2.68 (+1.31%) ▲|ORCL123.15-7.52 (-5.76%) ▼|PEP139.14+1.80 (+1.31%) ▲|PFE30.44-0.08 (-0.26%) ▼|PG162.80+1.23 (+0.76%) ▲|PLTR184.77+0.66 (+0.36%) ▲|PM207.53-1.27 (-0.61%) ▼|QCOM167.25+2.46 (+1.49%) ▲|RTX200.75+0.95 (+0.48%) ▲|SBUX103.09-0.56 (-0.54%) ▼|SCHW89.12+1.07 (+1.22%) ▲|SO93.68-0.03 (-0.03%) ▼|SPG221.57+3.82 (+1.75%) ▲|T21.54+0.13 (+0.61%) ▲|TMO682.98-14.02 (-2.01%) ▼|TMUS157.86+1.42 (+0.91%) ▲|TSLA411.73+11.92 (+2.98%) ▲|TXN308.26+7.42 (+2.47%) ▲|UBER67.26+2.01 (+3.08%) ▲|UNH396.22-10.75 (-2.64%) ▼|UNP306.96+2.96 (+0.97%) ▲|UPS109.47+1.22 (+1.13%) ▲|USB60.27+0.82 (+1.38%) ▲|V425.29+11.70 (+2.83%) ▲|VZ45.12+0.39 (+0.86%) ▲|WFC84.73+1.33 (+1.59%) ▲|WMT126.05+2.54 (+2.06%) ▲|XOM181.41-5.84 (-3.12%) ▼|AAPL338.30-6.34 (-1.84%) ▼|ABBV287.75-7.14 (-2.42%) ▼|ABT108.53+2.33 (+2.19%) ▲|ACN260.97+2.73 (+1.06%) ▲|ADBE252.72+2.49 (+0.99%) ▲|AMAT393.50+3.41 (+0.87%) ▲|AMD492.72-12.09 (-2.39%) ▼|AMGN461.53-4.48 (-0.96%) ▼|AMT187.25-0.53 (-0.28%) ▼|AMZN251.70+11.35 (+4.72%) ▲|AVGO332.70+6.62 (+2.03%) ▲|AXP327.48+8.37 (+2.62%) ▲|BA176.42+4.87 (+2.84%) ▲|BAC50.02+0.01 (+0.02%) ▲|BKNG155.00+6.87 (+4.64%) ▲|BLK1,174.36+26.82 (+2.34%) ▲|BMY62.54+0.06 (+0.09%) ▲|BNY148.04+0.93 (+0.63%) ▲|BRK-B550.78+8.29 (+1.53%) ▲|C123.59+1.62 (+1.33%) ▲|CAT619.65-3.10 (-0.50%) ▼|CL96.39+1.10 (+1.15%) ▲|CMCSA23.62+0.40 (+1.70%) ▲|COF210.48+5.63 (+2.75%) ▲|COP149.02-5.02 (-3.26%) ▼|COST1,027.81+15.53 (+1.53%) ▲|CRM231.15+1.98 (+0.86%) ▲|CSCO103.54-0.97 (-0.93%) ▼|CVS88.29-1.96 (-2.17%) ▼|CVX231.07-4.46 (-1.89%) ▼|DE674.37-1.11 (-0.16%) ▼|DHR228.23-4.00 (-1.72%) ▼|DIS112.91+1.97 (+1.78%) ▲|DUK127.09-0.30 (-0.24%) ▼|EMR168.84+3.90 (+2.36%) ▲|FDX320.10+6.82 (+2.18%) ▲|GD369.87-2.72 (-0.73%) ▼|GE313.61+11.81 (+3.91%) ▲|GEV889.40+31.53 (+3.68%) ▲|GILD167.87-2.81 (-1.65%) ▼|GM89.32+1.92 (+2.20%) ▲|GOOG281.51+3.29 (+1.18%) ▲|GOOGL283.11+3.27 (+1.17%) ▲|GS911.73+17.18 (+1.92%) ▲|HD338.79+9.59 (+2.91%) ▲|HON224.57+6.24 (+2.86%) ▲|IBM259.55+1.74 (+0.67%) ▲|INTC63.06-2.71 (-4.11%) ▼|INTU351.96+10.87 (+3.19%) ▲|ISRG440.39+8.38 (+1.94%) ▲|JNJ268.46-4.74 (-1.74%) ▼|JPM340.52+3.48 (+1.03%) ▲|KO95.08+1.00 (+1.06%) ▲|LIN520.56+6.32 (+1.23%) ▲|LLY1,409.41-8.14 (-0.57%) ▼|LMT637.85+0.90 (+0.14%) ▲|LOW216.09+7.02 (+3.36%) ▲|LRCX236.32-2.80 (-1.17%) ▼|MA657.31+19.30 (+3.02%) ▲|MCD263.20+5.08 (+1.97%) ▲|MDLZ65.78+0.84 (+1.29%) ▲|MDT97.69+1.15 (+1.19%) ▲|META610.35-4.64 (-0.75%) ▼|MMM179.02+4.68 (+2.68%) ▲|MO77.53-0.51 (-0.65%) ▼|MRK148.15-1.37 (-0.92%) ▼|MS186.83+2.53 (+1.37%) ▲|MSFT524.18+2.27 (+0.43%) ▲|MU868.15-16.59 (-1.88%) ▼|NEE84.44+0.73 (+0.87%) ▲|NFLX62.01-0.07 (-0.11%) ▼|NKE39.35+0.68 (+1.76%) ▲|NOW107.66+2.54 (+2.42%) ▲|NVDA207.32+2.68 (+1.31%) ▲|ORCL123.15-7.52 (-5.76%) ▼|PEP139.14+1.80 (+1.31%) ▲|PFE30.44-0.08 (-0.26%) ▼|PG162.80+1.23 (+0.76%) ▲|PLTR184.77+0.66 (+0.36%) ▲|PM207.53-1.27 (-0.61%) ▼|QCOM167.25+2.46 (+1.49%) ▲|RTX200.75+0.95 (+0.48%) ▲|SBUX103.09-0.56 (-0.54%) ▼|SCHW89.12+1.07 (+1.22%) ▲|SO93.68-0.03 (-0.03%) ▼|SPG221.57+3.82 (+1.75%) ▲|T21.54+0.13 (+0.61%) ▲|TMO682.98-14.02 (-2.01%) ▼|TMUS157.86+1.42 (+0.91%) ▲|TSLA411.73+11.92 (+2.98%) ▲|TXN308.26+7.42 (+2.47%) ▲|UBER67.26+2.01 (+3.08%) ▲|UNH396.22-10.75 (-2.64%) ▼|UNP306.96+2.96 (+0.97%) ▲|UPS109.47+1.22 (+1.13%) ▲|USB60.27+0.82 (+1.38%) ▲|V425.29+11.70 (+2.83%) ▲|VZ45.12+0.39 (+0.86%) ▲|WFC84.73+1.33 (+1.59%) ▲|WMT126.05+2.54 (+2.06%) ▲|XOM181.41-5.84 (-3.12%) ▼|
17 C
New York
Monday, November 2, 2026

Tag: engagement

BIC : Bilan semestriel du contrat de liquidité

Bilan semestriel du contrat de liquidité Société BIC

MemeCore Announces $M Token Listing on Major Centralized Exchanges

Trading Commenced on 03 July 2025. Celebratory Campaigns to Launch Across Platforms SINGAPORE, July 4, 2025 /PRNewswire/ -- MemeCore, the world's first Layer 1 blockchain...

Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

NeuroEnergizer 2025 Update Positions OTC Audio Program at Forefront of Cognitive Wellness Movement

Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.
Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.

High-Potency OTC NMN Supplement from Wonderfeel Launches Amid Surging Demand for Clean NAD+ Support Solutions

Wonderfeel’s 2025 Youngr™ update features a 900mg stabilized NMN dose with antioxidant co-factors, formulated to align with consumer interest in bioavailable, non-synthetic NAD+ wellness support.
Wonderfeel’s 2025 Youngr™ update features a 900mg stabilized NMN dose with antioxidant co-factors, formulated to align with consumer interest in bioavailable, non-synthetic NAD+ wellness support.

Neuro Balance Therapy Update: Strongest Non-Clinical Reflex Routine for Seniors Concerned About Instability

New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+
New 2025 At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in Adults 60+

Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support

Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness
Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness

Bioma Probiotics Redefines Digestive Health in 2025 With Its Strongest Prebiotic, Probiotic, and Postbiotic Synergy Yet

Bioma’s transparency-driven formula highlights XOS prebiotics, targeted Bifidobacterium strains, and tributyrin postbiotics—meeting rising consumer demand for non-synthetic gut health support without promotional claims.
Bioma’s transparency-driven formula highlights XOS prebiotics, targeted Bifidobacterium strains, and tributyrin postbiotics—meeting rising consumer demand for non-synthetic gut health support without promotional claims.

Brain Defender Enters 2025 Cognitive Wellness Spotlight as Demand for Transparent, Non-Stimulant Support Surges

As consumers turn to ingredient-based mental clarity tools, Brain Defender emphasizes formulation transparency and non-clinical support in the evolving cognitive wellness space.
As consumers turn to ingredient-based mental clarity tools, Brain Defender emphasizes formulation transparency and non-clinical support in the evolving cognitive wellness space.

Ervin Cohen & Jessup Guides High-Growth Apparel Brand DÔEN Through Major Capital Raise

BEVERLY HILLS, Calif., July 3, 2025 /PRNewswire/ -- Ervin Cohen & Jessup LLP (ECJ) announced today its representation of DÔEN, a long-standing client and California-based...

Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines

Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines

Wealth Megatrends Releases 2025 Forecast Update on Gold Prediction Amid Historic Surge in Central Bank Demand

In this 2025 forecast update, Wealth Megatrends, in collaboration with Weiss Ratings, offers unique insights into gold's continued upward trajectory. The release outlines Sean Brodrick's updated projection of $6,900 gold, framed within rising central bank demand, ongoing monetary volatility, and long-term shifts in asset preservation behavior. This analysis offers a distinct perspective on how this cycle compares to prior periods of financial instability and why mining equities are again drawing interest as part of a broader conversation on gold's role in today's evolving macroeconomic environment.
In this 2025 forecast update, Wealth Megatrends, in collaboration with Weiss Ratings, offers unique insights into gold's continued upward trajectory. The release outlines Sean Brodrick's updated projection of $6,900 gold, framed within rising central bank demand, ongoing monetary volatility, and long-term shifts in asset preservation behavior. This analysis offers a distinct perspective on how this cycle compares to prior periods of financial instability and why mining equities are again drawing interest as part of a broader conversation on gold's role in today's evolving macroeconomic environment.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsEngagement